Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase I Clinical study of N-LIfT

Next Previous
Trial Profile

A phase I Clinical study of N-LIfT

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 05 May 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 28 Apr 2025 According to a LIfT Biosciences media release,Following the completion of the current funding round, the company anticipates entering the clinic in 2026, pending final regulatory approvals.
  • 28 Apr 2025 According to a LIfT Biosciences media release, company announces partnership with the University of Galway, and Hooke Bio, experts in clinical analytics and biomarkers for advancement in this trial.
  • 24 Sep 2024 According to a LIfT Biosciences media release, the company has successfully raised 10 million pound in the first close of a Series A financing with the second close scheduled for Q1 2025. Ffunds raised will be used to advance the Company's IMANs into clinical trials through a Phase I Investigator Initiated Trial with Galway University.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top